A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin-5

European Journal of Haematology

Volumn 70, Issue 2, 2003, Pages 115-118

  Ishii, Taeko ^a,b   Tatekawa, Toyoshi ^a   Koseto, Masahiro ^a   Ishii, Masaru ^b   Kobayashi, Hideyuki ^c   Koike, Masato ^d   Fujii, Takashi ^a   Saeki, Yukihiko ^b  

^a Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOWA COMPANY LTD   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Eosinophilia; Interleukin 5; Multicentric Castelman's disease

Indexed keywords

INTERLEUKIN 5; INTERLEUKIN 6; PREDNISOLONE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD CULTURE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; EOSINOPHILIA; ERYTHROCYTE SEDIMENTATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEROLOGY;

ADULT; EOSINOPHILIA; GIANT LYMPH NODE HYPERPLASIA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-5; INTERLEUKIN-6; LYMPH NODES; MALE; PLASMA CELLS;

EID: 0037331555     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00018.x     Document Type: Article

References (16)

1. CASTLEMAN B, IVERSON L, MENENDEZ VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956;9:822-830.
2. KELLER AR, HOCHHOLZER L, CASTLEMAN B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670-683.
3. KISHIMOTO T, AKIRA S, TAGA T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992;258:593-597.
4. YABUHARA A, YANAGISAWA M, MURATA T, Kawai H, KOMIYAMA A, AKABANE T, ITOH M, ISHII E, FUJIMOTO J, HATA J. Giant lymph node hyperplasia (Castleman's disease) with spontaneous production of high levels of B-cell differentiation factor activity. Cancer 1989;63:260-265.
5. YOSHIZAKI K, MATSUDA T, NISHIMOTO N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989;74:1360-1367.
6. BRANDT SJ, BODINE DM, DUNBAR CE, NIENHUIS AW. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 1990;86:592-599.
7. LEGER-RAVET MB, PEUCHMAUR M, DEVERGNE O, AUDOUIN J, RAPHAEL M, VAN DAMME J, GALANAUD P, DIEBOLD J, EMILIE D. Interleukin-6 gene expression in Castleman's disease. Blood 1991;78:2923-2930.
8. GABA AR, STEIN RS, SWEET DL, VARIAKOJIS D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978;69:86-90.
9. BARTOLI E, MASSARELLI G, SOGGIA G, TANDA F. Multicentric giant lymph node hyperplasia. A hyperimmune syndrome with a rapidly progressive course. Am J Clin Pathol 1980;73:423-426.
10. FRIZZERA G, PETERSON BA, BAYRD ED, GOLDMAN A. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 1985;3:1202-1216.
11. BOWNE WB, LEWIS JJ, FILIPPA DA, NIESVIZKY R, BROOKS AD, BURT ME, BRENNAN MF. The management of unicentric and multicentric Castleman's disease. A report of 16 cases and a review of the literature. Cancer 1999;85:706-717.
12. SANDERSON CJ, WARREN DJ, STRATH M. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J Exp Med 1985;162:60-74.
13. SANDERSON CJ, CAMPBELL HD, YOUNG IG. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol Rev 1988;102:29-50.
14. HSU SM, RAINE L. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 1981;29:1349-1353.
15. SOULIER J, GROLLET L, OKSENHENDLER E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-1280.
16. DUPIN N, DISS TL, KELLAM P, TULLIEZ M, DU M-Q, SICARD D, WEISS RA, ISAACSON PG, BOSHOFF C. HHV-8 is associated with a plasmablastic variant of Castleman's disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000;95:1406-1412.